Bacille Calmette-Guérin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families - PubMed (original) (raw)
Case Reports
. 2010 Sep:14 Suppl 3:e256-60.
doi: 10.1016/j.ijid.2009.11.005. Epub 2010 Feb 19.
Affiliations
- PMID: 20171917
- DOI: 10.1016/j.ijid.2009.11.005
Free article
Case Reports
Bacille Calmette-Guérin infection and disease with fatal outcome associated with a point mutation in the interleukin-12/interleukin-23 receptor beta-1 chain in two Mexican families
Sigifredo Pedraza-Sánchez et al. Int J Infect Dis. 2010 Sep.
Free article
Abstract
Patients with Mendelian susceptibility to mycobacterial diseases (MSMD) mainly suffer from Mycobacterium and Salmonella infections, which are due to mutations in genes controlling the interleukin (IL)-12/IL-23-dependent IFN-γ production. We performed a molecular diagnosis in two Mexican patients with persistent mycobacterial infections. Patients 1 (P1) and 2 (P2) from two unrelated, non-consanguineous families from two villages near Mexico City developed bacille Calmette-Guérin (BCG) disease secondary to vaccination; patients and their families were studied at the immunological level for production and response to IFN-γ. The β1 subunit of the IL-12 receptor (encoded by the IL12RB1 gene) was not expressed in cells from P1 or P2, or in two siblings of P1. Sequencing of the IL12RB1 gene showed the same point mutation 1791+2 T>G, homozygous in patients and heterozygous in parents. P1 and P2 died at the ages of 4 and 16 years, respectively, with disseminated and uncontrolled BCG disease and with Candida albicans infections in spite of multiple anti-mycobacterial drug treatments. One of P2's siblings also died following disseminated mycobacterial infection secondary to BCG vaccination. These are the first cases in Mexico of patients with BCG disease traced to a mutation in the IL12RB1 gene, with a fatal outcome. Doctors must be alert to the adverse reactions to BCG vaccination and to persistent Mycobacterium infections, and in such cases should investigate possible mutations in the genes of the IL-12/IL-23-IFN-γ axis.
Copyright © 2010 International Society for Infectious Diseases. All rights reserved.
Similar articles
- Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guérin infection.
Elloumi-Zghal H, Barbouche MR, Chemli J, Béjaoui M, Harbi A, Snoussi N, Abdelhak S, Dellagi K. Elloumi-Zghal H, et al. J Infect Dis. 2002 May 15;185(10):1468-75. doi: 10.1086/340510. Epub 2002 Apr 30. J Infect Dis. 2002. PMID: 11992283 - Partial interferon-gamma receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guérin infection and a sibling with clinical tuberculosis.
Jouanguy E, Lamhamedi-Cherradi S, Altare F, Fondanèche MC, Tuerlinckx D, Blanche S, Emile JF, Gaillard JL, Schreiber R, Levin M, Fischer A, Hivroz C, Casanova JL. Jouanguy E, et al. J Clin Invest. 1997 Dec 1;100(11):2658-64. doi: 10.1172/JCI119810. J Clin Invest. 1997. PMID: 9389728 Free PMC article. - Disseminated bacille Calmette-Guérin infection in an infant with a novel deletion in the interferon-gamma receptor gene.
Cunningham JA, Kellner JD, Bridge PJ, Trevenen CL, Mcleod DR, Davies HD. Cunningham JA, et al. Int J Tuberc Lung Dis. 2000 Aug;4(8):791-4. Int J Tuberc Lung Dis. 2000. PMID: 10949334 - [Novel vaccines against M. tuberculosis].
Okada M. Okada M. Kekkaku. 2006 Dec;81(12):745-51. Kekkaku. 2006. PMID: 17240920 Review. Japanese. - Control of human host immunity to mycobacteria.
Ottenhoff TH, Verreck FA, Hoeve MA, van de Vosse E. Ottenhoff TH, et al. Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):53-64. doi: 10.1016/j.tube.2004.09.011. Epub 2004 Dec 31. Tuberculosis (Edinb). 2005. PMID: 15687028 Review.
Cited by
- An Updated Review on MSMD Research Globally and A Literature Review on the Molecular Findings, Clinical Manifestations, and Treatment Approaches in China.
Xia L, Liu XH, Yuan Y, Lowrie DB, Fan XY, Li T, Hu ZD, Lu SH. Xia L, et al. Front Immunol. 2022 Jul 18;13:926781. doi: 10.3389/fimmu.2022.926781. eCollection 2022. Front Immunol. 2022. PMID: 36569938 Free PMC article. Review. - Immunological Evaluation for Personalized Interventions in Children with Tuberculosis: Should It Be Routinely Performed?
Carreto-Binaghi LE, Juárez E, Guzmán-Beltrán S, Herrera MT, Torres M, Alejandre A, Martínez-Orozco JA, Becerril-Vargas E, Gonzalez Y. Carreto-Binaghi LE, et al. J Immunol Res. 2020 Sep 14;2020:8235149. doi: 10.1155/2020/8235149. eCollection 2020. J Immunol Res. 2020. PMID: 33005692 Free PMC article. - The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis.
Wei XQ, Rogers H, Lewis MA, Williams DW. Wei XQ, et al. Clin Dev Immunol. 2011;2011:697340. doi: 10.1155/2011/697340. Epub 2010 Oct 24. Clin Dev Immunol. 2011. PMID: 20981280 Free PMC article. Review. - TNF-α blockade impairs in vitro tuberculous granuloma formation and down modulate Th1, Th17 and Treg cytokines.
Silva DAAD, Silva MVD, Barros CCO, Alexandre PBD, Timóteo RP, Catarino JS, Sales-Campos H, Machado JR, Rodrigues DBR, Oliveira CJ, Rodrigues V. Silva DAAD, et al. PLoS One. 2018 Mar 15;13(3):e0194430. doi: 10.1371/journal.pone.0194430. eCollection 2018. PLoS One. 2018. PMID: 29543912 Free PMC article. - Discovering the link between IL12RB1 gene polymorphisms and tuberculosis susceptibility: a comprehensive meta-analysis.
Huang J, He Q, Huang L, Liu L, Yang P, Chen M. Huang J, et al. Front Public Health. 2024 Jan 22;12:1249880. doi: 10.3389/fpubh.2024.1249880. eCollection 2024. Front Public Health. 2024. PMID: 38317798 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical